Literature DB >> 11323224

Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein.

S Taniuchi1, J Chihara, T Kojima, A Yamamoto, M Sasai, Y Kobayashi.   

Abstract

Serum levels of eosinophil cationic protein (ECP) have been shown to be a good parameter of the disease severity of patients with atopic dermatitis (AD). However, the relationship between the disease severity and the eosinophil derived neurotoxin (EDN) has not been established in AD patients. The purpose of this study is to examine serum ECP and EDN levels in relation to the disease severity in AD children. Serum ECP and EDN levels were assessed in relation to the skin scores in 34 AD children (18 boys and 16 girls; age 0.6 to 7years: mean+/-S.D. 2.2+/-1.9) and six non-atopic control children (three boys and three girls; age 1 to 3years: mean+/-S.D. 1.7+/-0.9). Serum ECP and EDN levels of the patients with AD were significantly increased compared with the non-atopic controls. Serum EDN levels of the patients were also related to the disease severity. The skin scores were more significantly correlated with serum EDN levels than ECP levels. We concluded that serum EDN may reflect more strongly disease severity as eosinophilic activation in AD children than serum ECP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11323224     DOI: 10.1016/s0923-1811(00)00151-1

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  13 in total

Review 1.  Molecular biology of atopic dermatitis.

Authors:  Zhanglei Mu; Yan Zhao; Xiaojing Liu; Christopher Chang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 2.  IgE, mast cells, and eosinophils in atopic dermatitis.

Authors:  Fu-Tong Liu; Heidi Goodarzi; Huan-Yuan Chen
Journal:  Clin Rev Allergy Immunol       Date:  2011-12       Impact factor: 8.667

3.  Toll-like receptor 2 is important for the T(H)1 response to cutaneous sensitization.

Authors:  Haoli Jin; Lalit Kumar; Clinton Mathias; David Zurakowski; Hans Oettgen; Leonid Gorelik; Raif Geha
Journal:  J Allergy Clin Immunol       Date:  2009-04       Impact factor: 10.793

4.  Eosinophils increase neuron branching in human and murine skin and in vitro.

Authors:  Erin L Foster; Eric L Simpson; Lorna J Fredrikson; James J Lee; Nancy A Lee; Allison D Fryer; David B Jacoby
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

5.  Infection, eosinophilia and childhood asthma.

Authors:  Chang-Keun Kim; Zak Callaway; Takao Fujisawa
Journal:  Asia Pac Allergy       Date:  2012-01-31

6.  Activation of eosinophils interacting with dermal fibroblasts by pruritogenic cytokine IL-31 and alarmin IL-33: implications in atopic dermatitis.

Authors:  Chun-Kwok Wong; Karen Ming-Lam Leung; Huai-Na Qiu; Joyce Yin-Sau Chow; Angela On Kei Choi; Christopher Wai-Kei Lam
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

7.  Association of FLG single nucleotide variations with clinical phenotypes of atopic dermatitis.

Authors:  Myungshin Kim; Jaeeun Yoo; Jiyeon Kim; Joonhong Park; Eunhee Han; Woori Jang; Hyojin Chae; Ji Hyun Lee; Young Min Park; Yonggoo Kim
Journal:  PLoS One       Date:  2017-12-27       Impact factor: 3.240

8.  Eosinophil-derived neurotoxin: a novel biomarker for diagnosis and monitoring of asthma.

Authors:  Chang-Keun Kim
Journal:  Korean J Pediatr       Date:  2013-01-29

Review 9.  Cellular aspects of atopic dermatitis.

Authors:  Liang-Shiou Ou; Jing-Long Huang
Journal:  Clin Rev Allergy Immunol       Date:  2007-12       Impact factor: 10.817

10.  Montelukast Reduces Serum Levels of Eosinophil-Derived Neurotoxin in Preschool Asthma.

Authors:  Chang Keun Kim; Zak Callaway; Jin Sung Park; Hisashi Nishimori; Tikatoshi Ogino; Mizuho Nagao; Takao Fujisawa
Journal:  Allergy Asthma Immunol Res       Date:  2018-11       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.